Maya Martinez-Davis
Corporate Officer/Principal bei GSK PLC
Aktive Positionen von Maya Martinez-Davis
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
GSK PLC | Corporate Officer/Principal | 01.01.2020 | - |
Karriereverlauf von Maya Martinez-Davis
Ehemalige bekannte Positionen von Maya Martinez-Davis
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MIRATI THERAPEUTICS | Director/Board Member | 06.12.2018 | 23.01.2024 |
Independent Dir/Board Member | 06.12.2018 | 23.01.2024 | |
MERCK KGAA | Corporate Officer/Principal | 01.01.2016 | 01.08.2019 |
Ausbildung von Maya Martinez-Davis
St. Louis University | Undergraduate Degree |
Instituto de Empresa SL | Graduate Degree |
Statistik
International
Vereinigte Staaten | 3 |
Deutschland | 2 |
Vereinigtes Königreich | 2 |
Operativ
Corporate Officer/Principal | 2 |
Director/Board Member | 1 |
Independent Dir/Board Member | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
MERCK KGAA | Health Technology |
GSK PLC | Health Technology |
Private Unternehmen | 1 |
---|---|
Mirati Therapeutics, Inc.
Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
- Börse
- Insiders
- Maya Martinez-Davis
- Erfahrung